Subscribe to our free daily newsletters
. Earth Science News .




Subscribe to our free daily newsletters



EPIDEMICS
Army-developed Zika vaccine induces strong immune response in three phase 1 studies
by Staff Writers
Silver Spring MD (SPX) Dec 07, 2017


WRAIR scientists working at bench preparing Army-developed Zika Purified Inactivated Virus (ZPIV) vaccine candidate.

Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Initial findings from the trials were published in The Lancet.

Each of the three studies included in the paper was designed to address a unique question about background immunity, vaccine dose or vaccination schedule. A fourth trial with ZPIV is still underway in Puerto Rico, where the population has natural exposure to other viruses in the same family as Zika (flaviviruses) such as dengue.

"It is imperative to developa vaccine that prevents severe birth defects and other neurologic complications in babies caused by Zika virus infection during pregnancy," said Dr. Kayvon Modjarrad, WRAIR's Director for Emerging Infectious Diseases, the Zika program co-lead and the article's lead author. "These results give us hope that a safe and effective vaccine will be achievable."

Across the three trials, a total of 67 healthy adult volunteers (55 vaccine, 12 placebo) received two vaccine injections, four weeks apart. Researchers measured the immune response by monitoring levels of Zika virus-neutralizing antibodies in the blood. More than 90% of volunteers who received the vaccine developed an immune response against Zika.

Not only is the development of a Zika vaccine a global public health priority, but it is also necessary to protect Service Members and their families," said Col. Nelson Michael, director of WRAIR's Military HIV Research Program (MHRP) and Zika program co-lead.

The ZPIV vaccine candidate was developed as part of the U.S. Department of Defense response to the 2015 outbreak of Zika virus in the Americas. WRAIR researchers conceived the ZPIV vaccine in February 2016 and were able to advance the candidate to a Phase 1 human trial by November of the same year.

"WRAIR has previously steered to licensure a similar vaccine for Japanese encephalitis, a flavivirus in the same family as Zika, which helped speed our vaccine development effort," said Dr. Leyi Lin, who led one of the trials at WRAIR.

In the volunteers who received the vaccine, neutralizing antibody levels peaked two weeks after they completed the 2-dose vaccine series, and exceeded the threshold established in an earlier study needed to protect monkeys against a Zika virus challenge (Science. 2016 Sep 9; 353(6304):1129-32). Researchers also found that antibodies from vaccinated volunteers protected mice from a Zika virus challenge, providing insight into how this vaccine might prevent Zika infection.

Each study included in this aggregate analysis was designed to address a unique question around ZPIV vaccination:

+ WRAIR Clinical Trial Center in Silver Spring, Md.,is assessing the impact of pre-existing flavivirus immunity in volunteers who received either a licensed yellow fever or Japanese encephalitis vaccine prior to ZPIV.

+ Saint Louis University (SLU) in St. Louis, Mo. is evaluating the safety and immunogenicity of three different vaccine doses.

+ Beth Israel Deaconess Medical Center (BIDMC) in Boston, Mass. is evaluating three different ZPIV dosing schedules.

Next steps include evaluating how long vaccine-induced immunity lasts, and the impact of dose, schedule and background immunity. Michael added that "Army researchers are part of integrated, strategic US Government effort to develop a vaccine to protect against Zika."

The ZPIV program is led by Col. Michael and Dr. Modjarrad. The principal investigators at each of the study sites were Dr. Leyi Lin at WRAIR, Dr. Sarah L. George at SLU and Dr. Kathryn E. Stephenson at BIDMC. The sponsor of the investigational new drug (IND) application for two of the studies (WRAIR and SLU) is the National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID), part of the National Institutes of Health. The BIDMC study is investigator-sponsored (Dr. Kathryn Stephenson).

EPIDEMICS
World AIDS chief warns of risk for Africa's child brides
Abidjan (AFP) Dec 4, 2017
The head of the UN's AIDS agency on Monday urged African countries to protect young women and children who are bearing the brunt of the continent's AIDS epidemic. A sharp rise of people living with the human immunodeficiency virus (HIV) has now slowed, "but now is not the time to drop our guard," Michel Sidibe, executive director of UNAIDS, told the start of a six-day conference on HIV/AIDS ... read more

Related Links
Walter Reed Army Institute of Research
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.

SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only

Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Pole to pole, linemen hard at work restoring power in Puerto Rico

UN urges 'humanitarian pause' for Yemen

Identifying optimal adaptation of buildings threatened by hurricanes, climate change

Big changes for Florida with mass Puerto Rican immigration

EPIDEMICS
First step toward practical application of holographic memory with magnetic assist

UCLA engineers use deep learning to reconstruct holograms and improve optical microscopy

Study shows how to get sprayed metal coatings to stick

PPPL scientists deliver new high-resolution diagnostic to national laser facility

EPIDEMICS
Seagrass is a key fishing ground globally

Sea turtles' sad fate: from restaurant menus to plastic 'soup'

Sharks evolved aircraft-like attributes to suit habitats

There's a deeper fish in the sea

EPIDEMICS
Arctic, major fishing nations agree no fishing in Arctic, for now

Antarctic Selfie's Journey to Space via Disruption Tolerant Networking

Antarctic landscape insights keep ice loss forecasts on the radar

Operation IceBridge 2017: The Beauty of Ice

EPIDEMICS
Light green plants save nitrogen without sacrificing photosynthetic efficiency

What makes soil, soil? Researchers find hidden clues in DNA

Tokyo 2020 to feed IOC food from disaster-hit regions

Robotic device tracks plant growth at the cellular level

EPIDEMICS
Seismologists worried by tremors in DR Congo

Albania sends in military rescue as heavy rains trigger huge floods

Eruption clues: UNH researchers create snapshot of volcano plumbing

New early signals to quantify the magnitude of strong earthquakes

EPIDEMICS
Regional force deploys to Lesotho over security concerns

Mali justice minister resigns after activist's acquittal

Cash and history keep Europe as Africa's prime partner

China hails new Zimbabwe leader, denies role in transition

EPIDEMICS
Trump removes protection for swaths of Utah parks

Chimp females who leave home postpone parenthood

Long-term logging study demonstrates impacts on chimpanzees and gorillas

What grosses out a chimpanzee?




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News






The content herein, unless otherwise known to be public domain, are Copyright 1995-2017 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement